The Sapienza University of Rome, also called simply Sapienza or the University of Rome, and formally the Università degli Studi di Roma "La Sapienza", is a public research university located in Rome, Italy. It is one of the largest European universities by enrollments and one of the oldest in history, founded in 1303.

During the past decade, Sapienza University of Rome- Polo Pontino conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sapienza University of Rome- Polo Pontino" are "Cholelithiasis" (1 trials) and "Colonic Diverticula" (1 trials). Many other conditions were trialed in "Sapienza University of Rome- Polo Pontino" in a lesser frequency.

Most popular intervention types in "Sapienza University of Rome- Polo Pontino" are "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ampicillin-sulbactam" (1 trials), "Ciprofloxacin" (1 trials), "Colonoscopy" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sapienza University of Rome- Polo Pontino" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Sapienza University of Rome- Polo Pontino". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Sapienza University of Rome- Polo Pontino, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sapienza University of Rome- Polo Pontino, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".